ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Maravai LifeSciences Holdings Inc

Maravai LifeSciences Holdings Inc (MRVI)

7.84
-0.19
(-2.37%)
Closed November 07 3:00PM
5.98
-1.86
(-23.72%)
After Hours: 6:59PM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
5.98
Bid
5.97
Ask
5.98
Volume
2,623,283
7.745 Day's Range 8.14
4.52 52 Week Range 11.555
Market Cap
Previous Close
8.03
Open
8.09
Last Trade
31
@
5.98
Last Trade Time
Financial Volume
US$ 20,690,453
VWAP
7.8872
Average Volume (3m)
1,809,915
Shares Outstanding
252,237,419
Dividend Yield
-
PE Ratio
-16.55
Earnings Per Share (EPS)
-0.47
Revenue
292.23M
Net Profit
-119.03M

About Maravai LifeSciences Holdings Inc

Maravai LifeSciences Holdings Inc is a life sciences company. It provides products to enable the development of drug therapies, diagnostics, novel vaccines and support research on human diseases. The company's segments are Nucleic acid production, Biologics safety testing, and Protein detection. It ... Maravai LifeSciences Holdings Inc is a life sciences company. It provides products to enable the development of drug therapies, diagnostics, novel vaccines and support research on human diseases. The company's segments are Nucleic acid production, Biologics safety testing, and Protein detection. It generates a majority of its revenue from the Nucleic Acid Production that focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
-
Maravai LifeSciences Holdings Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker MRVI. The last closing price for Maravai LifeSciences was US$8.03. Over the last year, Maravai LifeSciences shares have traded in a share price range of US$ 4.52 to US$ 11.555.

Maravai LifeSciences currently has 252,237,419 shares outstanding. The market capitalization of Maravai LifeSciences is US$2.03 billion. Maravai LifeSciences has a price to earnings ratio (PE ratio) of -16.55.

MRVI Latest News

Maravai LifeSciences Reports Third Quarter 2024 Financial Results

Announces Agreement to Acquire the DNA and RNA business of Officinae Bio, Advancing Support for Innovative Nucleic Acid R&D SAN DIEGO, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Maravai...

Maravai LifeSciences To Host Earnings Conference Call on Thursday, November 7, 2024

SAN DIEGO, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators...

TriLink BioTechnologies® und Alphazyme bringen die neue CleanScribe™ RNA Polymerase auf den Markt

Arzneimittelentwicklern und Forschern können ab sofort das CleanScribe-Enzym nutzen, um die Bildung von dsRNA bei der mRNA-Synthese um bis zu 85 % zu reduzieren – ohne Beeinträchtigung von...

TriLink BioTechnologies® et Alphazyme collaborent pour lancer la nouvelle ARN polymérase CleanScribe™

Les développeurs de médicaments et les chercheurs peuvent désormais tirer parti de l’enzyme CleanScribe pour réduire la formation d’ARNdb jusqu’à 85 % lors de la synthèse d’ARNm, sans...

TriLink BioTechnologies® & Alphazyme Collaborate to Launch New CleanScribe™ RNA Polymerase

Drug developers & researchers can now leverage the CleanScribe enzyme to reduce dsRNA formation by up to 85% in mRNA synthesis without compromising mRNA yield, capping efficiency, or...

Cygnus Technologies and TriLink BioTechnologies® Collaborate to Launch AccuRes™ Host Cell DNA Quantification Kits

Cygnus’ AccuRes Kits to recover, amplify, & quantify remaining host cell DNA during biologic drug manufacturing to produce safer, more stable vaccines, therapies, and more Cygnus Technologies...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-1.65-21.6251638277.638.19275.8213535697.72342642CS
4-1.65-21.6251638277.638.5355.8213105267.72394681CS
12-2.44-28.97862232788.429.955.8218099158.58590333CS
26-3.11-34.21342134219.0911.5555.8219938488.58567753CS
52-0.79-11.66912850816.7711.5554.5222728437.55963356CS
156-30.52-83.616438356236.546.294.52205542815.55756271CS
260-25.13-80.777884924531.1163.554.52191063819.95471174CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CELUCelularity Inc
US$ 3.063
(111.24%)
46.67M
WBUYWeBuy Global Ltd
US$ 0.2371
(109.08%)
1.49B
MTENMingteng International Corporation Inc
US$ 6.73
(49.56%)
477.83k
NMHINatures Miracle Holding Inc
US$ 0.1425
(47.06%)
420.5M
APPApplovin Corporation
US$ 246.57
(46.29%)
18.62M
APPSDigital Turbine Inc
US$ 1.79
(-44.75%)
24.53M
XELAExela Technologies Inc
US$ 1.1801
(-40.40%)
2.48M
ALTOAlto Ingredients Inc
US$ 1.205
(-37.89%)
7.41M
SPPLSIMPPLE Ltd
US$ 0.8801
(-35.29%)
3.15M
XRAYDENTSPLY SIRONA Inc
US$ 17.25
(-28.07%)
30.1M
WBUYWeBuy Global Ltd
US$ 0.2371
(109.08%)
1.49B
NMHINatures Miracle Holding Inc
US$ 0.1425
(47.06%)
420.5M
XTIAXTI Aerospace Inc
US$ 0.0494
(-2.18%)
352.6M
ELABElevai Labs Inc
US$ 0.017916
(0.65%)
305.31M
NVDANVIDIA Corporation
US$ 148.88
(2.25%)
207.11M

MRVI Discussion

View Posts
Monksdream Monksdream 8 months ago
MRVI No 2 on the Barchart 100
https://www.barchart.com/stocks/performance/percent-change/advances?timeFrame=today&viewName=main&screener=overall&orderBy=percentChange&orderDir=desc
👍️0
Monksdream Monksdream 8 months ago
Early Barchart 100
https://www.barchart.com/stocks/performance/percent-change/advances?timeFrame=today&viewName=main&screener=overall&orderBy=percentChange&orderDir=desc
👍️0
crudeoil24 crudeoil24 4 years ago
Maravai LifeSciences stock price target raised to $50 from $31 at Stifel Nicolaus
7:24 am ET March 3, 2021 (MarketWatch)
👍️0
crudeoil24 crudeoil24 4 years ago
Maravai LifeSciences shares are trading higher after the company reported better-than-expected Q4 EPS and sales results and issued FY21 EPS and sales guidance above estimates.

Mar 3, 2021 7:35a ETBenzinga Stock Analysis
👍️0
crudeoil24 crudeoil24 4 years ago
Maravai LifeSciences Holdings, Inc. is a life sciences company. The Company provides products that enables the development of drug therapies, diagnostics, vaccines and support research on human diseases. The Company's segments include Nucleic Acid Production, Biologics Safety Testing, and Protein Detection. The Nucleic Acid Production segment manufactures and sells products used in the fields of gene therapy, nucleoside chemistry, oligonucleotide therapy and molecular diagnostics, including reagents used in the chemical synthesis, modification, labelling and purification of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). Its Biologics Safety Testing segment sells specialized analytical products for use in biologic manufacturing process development, including custom product-specific development antibody and assay development services. The Company's Protein Detection segment sells labeling and detection reagents for researchers in immunohistochemistry.
👍️0

Your Recent History

Delayed Upgrade Clock